MODERNIZATION

Rapid scientific advances are enabling a greater understanding of diseases at the molecular level; but at the same time, increasing clinical trial complexity and economic pressures have made the medicines development process more difficult. Novel medicine development tools (MDTs), such as real-world evidence (RWE), Bayesian statistical methods, and emerging digital technologies, can unlock systemic changes in medicines development and reverse these trends, but these MDTs have not been widely integrated into drug development programs and the clinical trial process because stakeholders throughout the ecosystem have not developed comfort and confidence in them. MDMI is executing a strategic process to bring stakeholders together to systematically develop that comfort and confidence and speed the development of medicines patients need.

Primary location: Washington United States